HRP990354B1 - New 4-substituted piperidines - Google Patents

New 4-substituted piperidines

Info

Publication number
HRP990354B1
HRP990354B1 HR990354A HRP990354A HRP990354B1 HR P990354 B1 HRP990354 B1 HR P990354B1 HR 990354 A HR990354 A HR 990354A HR P990354 A HRP990354 A HR P990354A HR P990354 B1 HRP990354 B1 HR P990354B1
Authority
HR
Croatia
Prior art keywords
substituted piperidines
new
amino
alkyl
aryl radicals
Prior art date
Application number
HR990354A
Other languages
English (en)
Croatian (hr)
Inventor
Orjales-Venero Aurelio
Toledo Avello Antonio
Pumar Duran Carmen
Original Assignee
Faes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes filed Critical Faes
Publication of HRP990354A2 publication Critical patent/HRP990354A2/hr
Publication of HRP990354B1 publication Critical patent/HRP990354B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR990354A 1998-11-18 1999-11-16 New 4-substituted piperidines HRP990354B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (2)

Publication Number Publication Date
HRP990354A2 HRP990354A2 (en) 2000-06-30
HRP990354B1 true HRP990354B1 (en) 2008-11-30

Family

ID=8305832

Family Applications (1)

Application Number Title Priority Date Filing Date
HR990354A HRP990354B1 (en) 1998-11-18 1999-11-16 New 4-substituted piperidines

Country Status (21)

Country Link
EP (1) EP1002794B1 (cs)
JP (1) JP4667552B2 (cs)
KR (1) KR100646675B1 (cs)
AR (1) AR028805A1 (cs)
AT (1) ATE422199T1 (cs)
AU (1) AU757177B2 (cs)
BR (1) BR9905634B1 (cs)
CA (1) CA2288533C (cs)
CY (1) CY1108955T1 (cs)
CZ (1) CZ296053B6 (cs)
DE (1) DE69940378D1 (cs)
DK (1) DK1002794T3 (cs)
ES (2) ES2157148B1 (cs)
HR (1) HRP990354B1 (cs)
HU (1) HU227558B1 (cs)
IL (1) IL132862A0 (cs)
NO (1) NO314401B1 (cs)
PL (1) PL196329B1 (cs)
PT (1) PT1002794E (cs)
RU (1) RU2232753C2 (cs)
TR (1) TR199902839A2 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1513510A1 (en) * 2002-05-30 2005-03-16 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
DE602005021871D1 (de) 2004-02-27 2010-07-29 Lilly Co Eli 4-aminopiperidinderivate als inhibitoren der monoamin-aufnahme
MXPA06014565A (es) 2004-06-18 2007-03-23 Wyeth Corp Procesos para preparar 6-alquil-5-arilsulfonil-dihidrofenantridinas.
EP1854785A1 (en) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
JP2010501542A (ja) * 2006-08-23 2010-01-21 ファイザー・プロダクツ・インク ピペリジン誘導体
EP2358675B9 (en) * 2008-11-14 2019-09-11 Theravance, Inc. 4-[2-(2-Fluorophenoxymethyl)phenyl]piperidine compounds
EP2419405A1 (en) * 2009-04-15 2012-02-22 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
EP2390248A1 (en) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
EP2576509A1 (en) 2010-05-24 2013-04-10 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Also Published As

Publication number Publication date
EP1002794B1 (en) 2009-02-04
HU227558B1 (en) 2011-08-29
ES2157148A1 (es) 2001-08-01
BR9905634A (pt) 2000-09-26
KR100646675B1 (ko) 2006-11-17
CZ296053B6 (cs) 2005-12-14
CA2288533C (en) 2009-01-06
NO995643D0 (no) 1999-11-17
RU2232753C2 (ru) 2004-07-20
TR199902839A3 (tr) 2000-09-21
HUP9904086A3 (en) 2001-11-28
CZ399599A3 (cs) 2000-08-16
AU757177B2 (en) 2003-02-06
BR9905634B1 (pt) 2012-09-04
HRP990354A2 (en) 2000-06-30
PL196329B1 (pl) 2007-12-31
DE69940378D1 (de) 2009-03-19
PT1002794E (pt) 2009-03-25
CA2288533A1 (en) 2000-05-18
ATE422199T1 (de) 2009-02-15
AU5936699A (en) 2000-05-25
NO995643L (no) 2000-05-19
NO314401B1 (no) 2003-03-17
JP2000154176A (ja) 2000-06-06
KR20000035525A (ko) 2000-06-26
ES2157148B1 (es) 2002-03-01
HUP9904086A2 (hu) 2000-11-28
PL336607A1 (en) 2000-05-22
IL132862A0 (en) 2001-03-19
AR028805A1 (es) 2003-05-28
TR199902839A2 (xx) 2000-09-21
JP4667552B2 (ja) 2011-04-13
HU9904086D0 (en) 2000-01-28
EP1002794A1 (en) 2000-05-24
ES2323742T3 (es) 2009-07-23
DK1002794T3 (da) 2009-04-14
CY1108955T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
RS53629B1 (en) CYAN ANTHRANYLAMIDE INSECTICIDES
ATE447569T1 (de) Pna-monomer und vorstufe
HRP990354B1 (en) New 4-substituted piperidines
DK0931788T3 (da) Metalloproteasehæmmere
RS50437B (sr) Benzoilpirazoli i njihova primena u ulozi herbicida
ATE453631T1 (de) Pna-monomer und vorstufe
CY1112005T1 (el) Νεα καρβοξαμιδια ως αναστολεις του παραγοντα χa
CY1111349T1 (el) Καρβαμιδικες ενωσεις προς χρηση στη θεραπεια του πονου
ATE283302T1 (de) Lumineszente polymere
CY1107199T1 (el) Καρβαμικες ενωσεις για χρηση στη προληψη ή τη θεραπευτικη αντιμετωπιση της διπολικης διαταραχης
CY1105330T1 (el) Καρβαμιδικα παραγωγα για χρηση στην προληψη ή την αγωγη της διπολικης διαταραχης
EA200301100A1 (ru) Новые фталазиноны
CY1107468T1 (el) Καρβαμιδικες ενωσεις για χρηση στην προληψη ή την αγωγη διαταραχων του αγχους
CY1109085T1 (el) Νεα αλατα
CY1110284T1 (el) Παραγωγα της 2-αμινο-4-πυριδυλομεθυλο-θειαζολινης και η χρηση τους ως αναστολεις της επαγωγιμης συνθασης νο
RS51055B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
ATE286711T1 (de) Oxidationsfärbemittel
ES2236203T3 (es) Derivados de quinolinil-piperidin-4-ilideno-metil-benzamida para el tratamiento del dolor.
RS51056B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja
DK268583D0 (da) Substituerede maleinsyreimider, fremgangsmade til fremstilling deraf og deres anvendelse som midler til bekaempelse af skadelige organismer
AR051389A1 (es) Procedimiento e intermediarios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenil-metilsulfonamida
NO995289L (no) Benzimidazol-derivater
CY1108075T1 (el) Διαδικασια για την παρασκευη αλκοξυκαρβονυλμεθοξυ-κυκλοπεντανιων
PT96805A (pt) Processo para a preparacao de 2,4,8-tri-substituido-3h,6h-1,4,5a,8a-tetra-aza-acenaftileno-3,5-(4h)-dionas
EA199900776A1 (ru) Производные сахарин-5-карбонилциклогексан-1,3,5-трионов

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20121114

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20131116